Cases 1 - 10 of 23
Azurity Pharmaceuticals, Inc. et al v. Glenmark Pharmaceuticals Limited et al
as 1:2022cv01604
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Apotex Inc. et al
as 1:2020cv00133
Defendant:
Bionpharma Inc., Strides Pharma, Inc., Prinston Pharmaceutical Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
Pfizer Inc. et al v. Glenmark Pharmaceuticals Limited et al
as 1:2019cv01209
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Glenmark Pharmaceuticals Limited and Glenmark Pharmaceuticals Inc., USA
Cause Of Action: 35 U.S.C. § 271
Eisai Co., Ltd. et al v. Glenmark Pharmaceuticals Limited et al
as 1:2019cv01214
Plaintiff:
Novartis Pharma AG, Eisai Inc. and Eisai Co., Ltd.
Defendant:
Glenmark Pharmaceuticals Limited, Glenmark Pharmaceuticals Inc., USA and Glenmark Generics Limited
Cause Of Action: 35 U.S.C. § 271
TARO PHARMACEUTICALS U.S.A., INC. et al v. GLENMARK PHARMACEUTICALS LTD. et al
as 2:2018cv12569
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
GLENMARK PHARMACEUTICALS LTD. and GLENMARK PHARMACEUTICALS INC., USA
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2018cv00460
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al
as 1:2017cv01653
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Glenmark Pharmaceuticals Limited , Glenmark Pharmaceuticals Inc., USA and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 271
ELI LILLY AND COMPANY et al v. GLENMARK PHARMACEUTICALS LIMITED et al
as 2:2017cv07024
Plaintiff:
ELI LILLY AND COMPANY and ICOS CORPORATION
Defendant:
GLENMARK PHARMACEUTICALS LIMITED and GLENMARK PHARMACEUTICALS INC., USA
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
